aspirin and Colitis
aspirin has been researched along with Colitis in 46 studies
Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.
Colitis: Inflammation of the COLON section of the large intestine (INTESTINE, LARGE), usually with symptoms such as DIARRHEA (often with blood and mucus), ABDOMINAL PAIN, and FEVER.
Research Excerpts
| Excerpt | Relevance | Reference |
|---|---|---|
| "Despite being shown to be effective for chemoprevention of colorectal cancer, aspirin has limitations including adverse effects and inability to block colitis-associated colon cancer (CAC)." | 8.31 | Combining gamma-tocopherol and aspirin synergistically suppresses colitis-associated colon tumorigenesis and modulates the gut microbiota in mice, and inhibits the growth of human colon cancer cells. ( Jiang, Q; Jones-Hall, Y; Liu, KY; Nakatsu, CH; Wang, Q, 2023) |
| " Here, we describe a 3-year-old boy with typical KD who had lower gastrointestinal bleeding caused by rectal ulcers on the third day of aspirin therapy." | 7.96 | A case of rectal ulcers during aspirin therapy in acute Kawasaki disease. ( Han, Y; Hu, C; Yu, Y, 2020) |
| " In this study, we investigated the anti-inflammatory effects of the aspirin-triggered resolvin D1 (AT-RvD1), its precursor (17(R)-hydroxy docosahexaenoic acid [17R-HDHA]) and resolvin D2 (RvD2) in dextran sulfate sodium (DSS)- or 2,4,6-trinitrobenzene sulfonic acid-induced colitis." | 7.77 | Omega-3 fatty acid-derived mediators 17(R)-hydroxy docosahexaenoic acid, aspirin-triggered resolvin D1 and resolvin D2 prevent experimental colitis in mice. ( Bento, AF; Calixto, JB; Claudino, RF; Dutra, RC; Marcon, R, 2011) |
| " The aim of this study was 1) to evaluate the relative importance of the GI microflora on the experimental colonic damage in the presence of caused by NSAID, and 2) to assess the efficacy of antibiotic treatment with ampicillin on the process of healing of colitis." | 7.77 | Antibiotic treatment with ampicillin accelerates the healing of colonic damage impaired by aspirin and coxib in the experimental colitis. Importance of intestinal bacteria, colonic microcirculation and proinflammatory cytokines. ( Brzozowski, T; Drozdowicz, D; Karczewska, E; Konturek, SJ; Krzysiek-Maczka, G; Pajdo, R; Pawlik, WW; Ptak-Belowska, A; Sliwowski, Z; Urbanczyk, K; Zwolinska-Wcislo, M, 2011) |
| "To determine the effect of non-selective cyclooxygenase (COX) inhibitors, selective COX-2 inhibitors and nitric oxide (NO)-releasing aspirin in the healing of ulcerative colitis." | 7.77 | Nitric oxide-releasing aspirin but not conventional aspirin improves healing of experimental colitis. ( Brzozowski, T; Kwiecien, S; Ptak-Belowska, A; Sliwowski, Z; Targosz, A; Urbanczyk, K; Zwolinska-Wcislo, M, 2011) |
| " We compared the effects of nimesulide, a preferential COX-2 inhibitor, with those of indomethacin, acetylsalicylic acid (ASA), and dexamethasone in a 24-h model of 2,4,6-trinitrobenzenesulfonic acid (TNBS)-induced colitis in the rat." | 7.71 | Effects of a COX-2 preferential agent nimesulide on TNBS-induced acute inflammation in the gut. ( Kankuri, E; Korpela, R; Moilanen, E; Paakkari, I; Vaali, K; Vapaatalo, H, 2001) |
| "Despite being shown to be effective for chemoprevention of colorectal cancer, aspirin has limitations including adverse effects and inability to block colitis-associated colon cancer (CAC)." | 4.31 | Combining gamma-tocopherol and aspirin synergistically suppresses colitis-associated colon tumorigenesis and modulates the gut microbiota in mice, and inhibits the growth of human colon cancer cells. ( Jiang, Q; Jones-Hall, Y; Liu, KY; Nakatsu, CH; Wang, Q, 2023) |
| " Here, we describe a 3-year-old boy with typical KD who had lower gastrointestinal bleeding caused by rectal ulcers on the third day of aspirin therapy." | 3.96 | A case of rectal ulcers during aspirin therapy in acute Kawasaki disease. ( Han, Y; Hu, C; Yu, Y, 2020) |
| " Our aim was to examine local and remote consequences of ASA-Tris administration in 2-,4-,6-trinitrobenzene-sulfonic acid (TNBS)-induced colitis as compared to ASA or mesalamine (5-aminosalicylate) treatment." | 3.88 | Acetylsalicylic acid-tris-hydroxymethyl-aminomethane reduces colon mucosal damage without causing gastric side effects in a rat model of colitis. ( Boros, M; Érces, D; Ghyczy, M; Hartmann, P; Jász, DK; Lajkó, N; Molnár, R; Szűcs, S; Tóth, G; Ugocsai, M; Varga, G, 2018) |
| " This study investigated the protective role of ASA in azoxymethane (AOM)-initiated and dextran sulfate sodium (DSS)-promoted colitis-associated colon cancer (CAC) and examined the epigenetic effects, particularly on histone 3 lysine 27 acetylation (H3K27ac), underlying the preventive effect of ASA." | 3.83 | The epigenetic effects of aspirin: the modification of histone H3 lysine 27 acetylation in the prevention of colon carcinogenesis in azoxymethane- and dextran sulfate sodium-treated CF-1 mice. ( Guo, Y; Huang, MT; Kong, AN; Li, W; Liu, Y; Su, ZY; Zhang, C, 2016) |
| " In this study, we investigated the anti-inflammatory effects of the aspirin-triggered resolvin D1 (AT-RvD1), its precursor (17(R)-hydroxy docosahexaenoic acid [17R-HDHA]) and resolvin D2 (RvD2) in dextran sulfate sodium (DSS)- or 2,4,6-trinitrobenzene sulfonic acid-induced colitis." | 3.77 | Omega-3 fatty acid-derived mediators 17(R)-hydroxy docosahexaenoic acid, aspirin-triggered resolvin D1 and resolvin D2 prevent experimental colitis in mice. ( Bento, AF; Calixto, JB; Claudino, RF; Dutra, RC; Marcon, R, 2011) |
| " The aim of this study was 1) to evaluate the relative importance of the GI microflora on the experimental colonic damage in the presence of caused by NSAID, and 2) to assess the efficacy of antibiotic treatment with ampicillin on the process of healing of colitis." | 3.77 | Antibiotic treatment with ampicillin accelerates the healing of colonic damage impaired by aspirin and coxib in the experimental colitis. Importance of intestinal bacteria, colonic microcirculation and proinflammatory cytokines. ( Brzozowski, T; Drozdowicz, D; Karczewska, E; Konturek, SJ; Krzysiek-Maczka, G; Pajdo, R; Pawlik, WW; Ptak-Belowska, A; Sliwowski, Z; Urbanczyk, K; Zwolinska-Wcislo, M, 2011) |
| "To determine the effect of non-selective cyclooxygenase (COX) inhibitors, selective COX-2 inhibitors and nitric oxide (NO)-releasing aspirin in the healing of ulcerative colitis." | 3.77 | Nitric oxide-releasing aspirin but not conventional aspirin improves healing of experimental colitis. ( Brzozowski, T; Kwiecien, S; Ptak-Belowska, A; Sliwowski, Z; Targosz, A; Urbanczyk, K; Zwolinska-Wcislo, M, 2011) |
| " We compared the effects of nimesulide, a preferential COX-2 inhibitor, with those of indomethacin, acetylsalicylic acid (ASA), and dexamethasone in a 24-h model of 2,4,6-trinitrobenzenesulfonic acid (TNBS)-induced colitis in the rat." | 3.71 | Effects of a COX-2 preferential agent nimesulide on TNBS-induced acute inflammation in the gut. ( Kankuri, E; Korpela, R; Moilanen, E; Paakkari, I; Vaali, K; Vapaatalo, H, 2001) |
| " The introduction of new classes of drugs has resulted in new adverse effects that require consideration in patients presenting with gastroenterological symptoms." | 2.43 | Drug-induced side effects affecting the gastrointestinal tract. ( Chan, FK; Leong, RW, 2006) |
| "In familial and sporadic colorectal cancer, aspirin, other nonsteroidal anti-inflammatory drugs and cyclo-oxygenase-2 inhibitors have been tested for their ability to reduce polyp and cancer development in clinical studies." | 2.42 | Review article: the chemoprevention of colorectal carcinoma. ( Gasche, C, 2004) |
| " In this review we also report 9 cases of colonic ulcers and 7 cases of diaphragm disease of the ascending colon, most of them associated with the long-term intake of slow release diclofenac." | 2.39 | [Nonsteroidal antirheumatic drugs and acetylsalicylic acid: adverse effects distal to the duodenum]. ( Gut, A; Halter, F; Ruchti, C, 1996) |
| "Colitis was induced in Wistar rats by intracolonic administration of 2,4,6-trinitrobenzenesulfonic acid (20 mg + 50% ethanol)." | 1.91 | Role of cyclooxygenases 1 and 2 in the maintenance of colonic mucosal integrity in an experimental colitis model. ( Barbosa, ALR; Costa-Filho, HB; Havt, A; Nicolau, LAD; Paula, SM; Queiroga, ML; Sales, TMAL; Soares, PMG; Souza, MHLP, 2023) |
| " We analyzed the risk of colonic mucosal lesions associated with the long-term use of LDA." | 1.37 | Colonic mucosal lesions associated with low-dose aspirin: a case control study. ( Beppu, K; Matsumoto, K; Nagahara, A; Ogihara, T; Ohkusa, T; Osada, T; Otaka, M; Sakamoto, N; Shibuya, T; Watanabe, S; Yokoyama, T, 2011) |
| "In addition, diverticular bleeding in the elderly was highly associated with intake of Aspirin." | 1.33 | [Epidemiology of gastrointestinal bleeding in the elderly]. ( Bertschinger, P; Bühler, H; Geyer, M; Stamenic, I, 2006) |
| "Colitis was induced in rats by an enema containing 2,4,6-trinitrobenzen sulfonic acid." | 1.32 | Decrease in non-selective, non-sustained attention induced by a chronic visceral inflammatory state as a new pain evaluation in rats. ( Ardid, D; Eschalier, A; Etienne, M; Jourdan, D; Millecamps, M, 2004) |
| "A renal biopsy showed a severe tubulointerstitial nephritis." | 1.27 | Naproxen-associated renal failure in a child with arthritis and inflammatory bowel disease. ( Balfe, JW; Baumal, R; Laxer, RM; Poucell, S; Silverman, ED, 1987) |
Research
Studies (46)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (15.22) | 18.7374 |
| 1990's | 3 (6.52) | 18.2507 |
| 2000's | 9 (19.57) | 29.6817 |
| 2010's | 16 (34.78) | 24.3611 |
| 2020's | 11 (23.91) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Kim, J | 1 |
| Kang, S | 1 |
| Hong, S | 1 |
| Yum, S | 1 |
| Kim, YM | 1 |
| Jung, Y | 1 |
| Babu, SSN | 1 |
| Singla, S | 1 |
| Jena, G | 1 |
| Zhang, SW | 1 |
| Xu, RH | 1 |
| Chen, D | 1 |
| Liu, KY | 1 |
| Wang, Q | 1 |
| Nakatsu, CH | 1 |
| Jones-Hall, Y | 1 |
| Jiang, Q | 1 |
| Costa-Filho, HB | 1 |
| Sales, TMAL | 1 |
| Paula, SM | 1 |
| Nicolau, LAD | 1 |
| Queiroga, ML | 1 |
| Havt, A | 1 |
| Soares, PMG | 1 |
| Barbosa, ALR | 1 |
| Souza, MHLP | 1 |
| Yu, T | 1 |
| Yan, B | 1 |
| Li, J | 1 |
| Zhang, T | 1 |
| Yang, R | 1 |
| Wang, X | 1 |
| Liu, Y | 4 |
| Liu, D | 2 |
| Zhuo, M | 1 |
| Chen, W | 1 |
| Shang, S | 1 |
| Guo, P | 1 |
| Peng, K | 1 |
| Li, M | 1 |
| Mo, P | 1 |
| Zhang, Y | 2 |
| Qiu, X | 1 |
| Li, W | 2 |
| Yu, C | 1 |
| Han, Y | 1 |
| Hu, C | 1 |
| Yu, Y | 1 |
| Zhao, R | 1 |
| Coker, OO | 1 |
| Wu, J | 1 |
| Zhou, Y | 1 |
| Zhao, L | 1 |
| Nakatsu, G | 1 |
| Bian, X | 1 |
| Wei, H | 1 |
| Chan, AWH | 1 |
| Sung, JJY | 1 |
| Chan, FKL | 1 |
| El-Omar, E | 1 |
| Yu, J | 1 |
| Elia, JR | 1 |
| Pekow, J | 1 |
| Patel, P | 1 |
| Ma, Y | 1 |
| Yin, Z | 1 |
| Li, L | 2 |
| Chen, B | 1 |
| Dai, H | 1 |
| Wu, D | 1 |
| Cong, J | 1 |
| Ye, L | 1 |
| Liao, C | 1 |
| Ye, Z | 1 |
| Huang, Z | 1 |
| Feng, Y | 1 |
| Tao, L | 1 |
| Wang, G | 1 |
| Li, Z | 1 |
| Yang, M | 1 |
| He, W | 1 |
| Zhong, X | 1 |
| Yang, J | 1 |
| Cheung, S | 1 |
| McDonald, F | 1 |
| Chen, L | 1 |
| Varga, G | 1 |
| Ugocsai, M | 1 |
| Hartmann, P | 1 |
| Lajkó, N | 1 |
| Molnár, R | 1 |
| Szűcs, S | 1 |
| Jász, DK | 1 |
| Érces, D | 1 |
| Ghyczy, M | 1 |
| Tóth, G | 1 |
| Boros, M | 1 |
| Ohnishi, Y | 1 |
| Mori, K | 1 |
| Inoue, M | 1 |
| Satake, N | 1 |
| Yano, M | 1 |
| Yang, RL | 1 |
| Yu, TT | 1 |
| Zhou, YH | 1 |
| Hammami, MB | 1 |
| Gill, R | 1 |
| Thiruvengadam, N | 1 |
| Oh, DY | 1 |
| Beck, K | 1 |
| Mahadevan, U | 1 |
| Kattah, MG | 1 |
| Köhnke, T | 1 |
| Gomolka, B | 1 |
| Bilal, S | 1 |
| Zhou, X | 1 |
| Sun, Y | 1 |
| Rothe, M | 1 |
| Baumgart, DC | 1 |
| Weylandt, KH | 1 |
| Tang, J | 1 |
| Xiong, J | 1 |
| Wu, T | 1 |
| Tang, Z | 1 |
| Ding, G | 1 |
| Zhang, C | 3 |
| Wang, S | 1 |
| Chen, C | 1 |
| Liu, S | 1 |
| Xu, X | 1 |
| Chen, X | 1 |
| Shi, S | 1 |
| Guo, Y | 2 |
| Su, ZY | 2 |
| Huang, MT | 1 |
| Kong, AN | 2 |
| Gaspar, JM | 1 |
| Wang, R | 1 |
| Hart, RP | 1 |
| Verzi, MP | 1 |
| Shibuya, T | 1 |
| Ohkusa, T | 1 |
| Yokoyama, T | 1 |
| Matsumoto, K | 1 |
| Beppu, K | 1 |
| Sakamoto, N | 1 |
| Osada, T | 1 |
| Nagahara, A | 1 |
| Otaka, M | 1 |
| Ogihara, T | 1 |
| Watanabe, S | 1 |
| Bento, AF | 1 |
| Claudino, RF | 1 |
| Dutra, RC | 1 |
| Marcon, R | 1 |
| Calixto, JB | 1 |
| Zwolinska-Wcislo, M | 2 |
| Krzysiek-Maczka, G | 1 |
| Ptak-Belowska, A | 2 |
| Karczewska, E | 1 |
| Pajdo, R | 1 |
| Sliwowski, Z | 2 |
| Urbanczyk, K | 2 |
| Drozdowicz, D | 1 |
| Konturek, SJ | 1 |
| Pawlik, WW | 1 |
| Brzozowski, T | 2 |
| Targosz, A | 1 |
| Kwiecien, S | 1 |
| Beaugerie, L | 1 |
| Gleeson, MH | 1 |
| Davis, AJ | 1 |
| Millecamps, M | 1 |
| Etienne, M | 1 |
| Jourdan, D | 1 |
| Eschalier, A | 1 |
| Ardid, D | 1 |
| Blassneck, K | 1 |
| Nusko, G | 1 |
| Niedobitek, G | 1 |
| Hahn, EG | 1 |
| Harsch, IA | 1 |
| Gasche, C | 1 |
| Vieth, M | 1 |
| Geyer, M | 1 |
| Stamenic, I | 1 |
| Bühler, H | 1 |
| Bertschinger, P | 1 |
| Leong, RW | 1 |
| Chan, FK | 1 |
| Pearson, DJ | 1 |
| Stones, NA | 1 |
| Bentley, SJ | 1 |
| Rutherford, D | 1 |
| Stockdill, G | 1 |
| Hamer-Hodges, DW | 1 |
| Ferguson, A | 1 |
| Brenna, E | 1 |
| Sandvik, AK | 1 |
| Kleveland, PM | 1 |
| Waldum, HL | 1 |
| Gut, A | 1 |
| Halter, F | 1 |
| Ruchti, C | 1 |
| Goere, D | 1 |
| Brocheriou-Spelle, I | 1 |
| Baron-Josselin, V | 1 |
| Salmeron, M | 1 |
| Houdart, R | 1 |
| Yagi, K | 1 |
| Nakamura, A | 1 |
| Sekine, A | 1 |
| Watanabe, H | 1 |
| Kankuri, E | 1 |
| Vaali, K | 1 |
| Korpela, R | 1 |
| Paakkari, I | 1 |
| Vapaatalo, H | 1 |
| Moilanen, E | 1 |
| Tamura, T | 1 |
| Laxer, RM | 1 |
| Silverman, ED | 1 |
| Balfe, JW | 1 |
| Poucell, S | 1 |
| Baumal, R | 1 |
| O'Brien, WM | 1 |
| Bagby, GF | 1 |
| Rose, MS | 1 |
| Leahy, MF | 1 |
| Stevens, A | 1 |
| Black, PJ | 1 |
| Barkhan, P | 1 |
| Baker, H | 1 |
Reviews
6 reviews available for aspirin and Colitis
| Article | Year |
|---|---|
Drug Exposure and Risk of Microscopic Colitis: A Systematic Review and Meta-Analysis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Colitis; Colitis, Microscopic; Diarrhea; Humans | 2023 |
Inflammatory bowel disease therapies and cancer risk: where are we and where are we going?
Topics: Aspirin; Colitis; Colorectal Neoplasms; Glucocorticoids; Humans; Immunosuppressive Agents; Inflammat | 2012 |
Review article: the chemoprevention of colorectal carcinoma.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Aspirin; Chemoprevention; Chromosoma | 2004 |
Drug-induced side effects affecting the gastrointestinal tract.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Bone Density Conservation Agents; Colitis; Colon; | 2006 |
[Nonsteroidal antirheumatic drugs and acetylsalicylic acid: adverse effects distal to the duodenum].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Colitis; Colitis, Ulcerative; Colonic Diseases; Co | 1996 |
Rare adverse reactions to nonsteroidal antiinflammatory drugs (3).
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents; Aspirin; Chemical and Drug Induced Liver Injury; | 1985 |
Other Studies
40 other studies available for aspirin and Colitis
| Article | Year |
|---|---|
Structure-activity relationship of salicylic acid derivatives on inhibition of TNF-α dependent NFκB activity: Implication on anti-inflammatory effect of N-(5-chlorosalicyloyl)phenethylamine against experimental colitis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Survival; Chemokine CXCL2; Colitis; HCT116 Ce | 2012 |
Role of Combination Treatment of Aspirin and Zinc in DMH-DSS-induced Colon Inflammation, Oxidative Stress and Tumour Progression in Male BALB/c Mice.
Topics: Animals; Antioxidants; Aspirin; Colitis; Colitis-Associated Neoplasms; Colon; Disease Models, Animal | 2023 |
Combining gamma-tocopherol and aspirin synergistically suppresses colitis-associated colon tumorigenesis and modulates the gut microbiota in mice, and inhibits the growth of human colon cancer cells.
Topics: Animals; Aspirin; Azoxymethane; Carcinogenesis; Cell Transformation, Neoplastic; Colitis; Colonic Ne | 2023 |
Role of cyclooxygenases 1 and 2 in the maintenance of colonic mucosal integrity in an experimental colitis model.
Topics: Animals; Aspirin; Colitis; Cyclooxygenase 2; Fluoresceins; Intestinal Mucosa; Peroxidase; Rats; Rats | 2023 |
Acetylsalicylic acid rescues the immunomodulation of inflamed gingiva-derived mesenchymal stem cells via upregulating FasL in mice.
Topics: Animals; Apoptosis; Aspirin; Colitis; Fas Ligand Protein; Gingiva; Immunomodulation; Male; Mesenchym | 2019 |
Inflammation-induced JMJD2D promotes colitis recovery and colon tumorigenesis by activating Hedgehog signaling.
Topics: Anilides; Animals; Aspirin; Carcinogenesis; Cell Proliferation; Colitis; Colorectal Neoplasms; Disea | 2020 |
A case of rectal ulcers during aspirin therapy in acute Kawasaki disease.
Topics: Aspirin; Child, Preschool; Colitis; Gastrointestinal Hemorrhage; Humans; Male; Mucocutaneous Lymph N | 2020 |
Aspirin Reduces Colorectal Tumor Development in Mice and Gut Microbes Reduce its Bioavailability and Chemopreventive Effects.
Topics: Adenomatous Polyposis Coli Protein; Animals; Anti-Bacterial Agents; Anticarcinogenic Agents; Aspirin | 2020 |
Aspirin, NSAIDs, and Inflammatory Bowel Disease: An Exercise Physiology Perspective.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Colitis; Humans; Inflammatory Bowel Diseases | 2020 |
Daily Aspirin Use Does Not Impact Clinical Outcomes in Patients With Inflammatory Bowel Disease. Reply Letter to Elia et al.
Topics: Aspirin; Colitis; Humans; Inflammatory Bowel Diseases | 2020 |
Food antigens exacerbate intestinal damage and inflammation following the disruption of the mucosal barrier.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Colitis; Collagen Type II; Disease Models | 2021 |
Aspirin inhibits prostaglandins to prevents colon tumor formation via down-regulating Wnt production.
Topics: Animals; Aspirin; Azoxymethane; Cell Transformation, Neoplastic; Colitis; Colitis-Associated Neoplas | 2021 |
Acetylsalicylic acid-tris-hydroxymethyl-aminomethane reduces colon mucosal damage without causing gastric side effects in a rat model of colitis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Colitis; Colon; Disease Models, Animal; I | 2018 |
A case of Kawasaki disease presenting as sigmoid colitis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Child, Preschool; Colitis; Colon, Sigmoid; Colonos | 2018 |
[Acetylsalicylic acid treatment enhanced immunomodulatory function of mesenchymal stem cells derived from gingiva].
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Aspirin; Colitis; Dextran Sulfate; Dise | 2017 |
Balancing the Checkpoint: Managing Colitis Associated with Dual Checkpoint Inhibitors and High-Dose Aspirin.
Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; As | 2019 |
Acetylsalicylic Acid reduces the severity of dextran sodium sulfate-induced colitis and increases the formation of anti-inflammatory lipid mediators.
Topics: Animals; Anti-Inflammatory Agents; Aspirin; Colitis; Dextran Sulfate; Docosahexaenoic Acids; Female; | 2013 |
Aspirin treatment improved mesenchymal stem cell immunomodulatory properties via the 15d-PGJ2/PPARγ/TGF-β1 pathway.
Topics: Animals; Apoptosis; Aspirin; Cell Proliferation; Cells, Cultured; Coculture Techniques; Colitis; Din | 2014 |
Acetylsalicylic acid treatment improves differentiation and immunomodulation of SHED.
Topics: Animals; Apoptosis; Aspirin; Bone Regeneration; Cell Culture Techniques; Cell Differentiation; Cell- | 2015 |
The epigenetic effects of aspirin: the modification of histone H3 lysine 27 acetylation in the prevention of colon carcinogenesis in azoxymethane- and dextran sulfate sodium-treated CF-1 mice.
Topics: Animals; Anticarcinogenic Agents; Aspirin; Azoxymethane; Colitis; Colonic Neoplasms; Cyclooxygenase | 2016 |
Mechanisms of colitis-accelerated colon carcinogenesis and its prevention with the combination of aspirin and curcumin: Transcriptomic analysis using RNA-seq.
Topics: Animals; Aspirin; Colitis; Colonic Neoplasms; Curcumin; Drug Therapy, Combination; Gene Expression P | 2017 |
Colonic mucosal lesions associated with low-dose aspirin: a case control study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aspirin; Colitis; Colonoscopy; Female; Humans; Intestina | 2011 |
Omega-3 fatty acid-derived mediators 17(R)-hydroxy docosahexaenoic acid, aspirin-triggered resolvin D1 and resolvin D2 prevent experimental colitis in mice.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Aspirin; Bone Marrow Cells | 2011 |
Antibiotic treatment with ampicillin accelerates the healing of colonic damage impaired by aspirin and coxib in the experimental colitis. Importance of intestinal bacteria, colonic microcirculation and proinflammatory cytokines.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Bacter | 2011 |
Nitric oxide-releasing aspirin but not conventional aspirin improves healing of experimental colitis.
Topics: Animals; Aspirin; Colitis; Colon; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Denervation; Dinopros | 2011 |
Non-steroidal anti-inflammatory drugs, aspirin and newly diagnosed colitis: a case-control study.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Case-Control Studies; Colitis; Female; Huma | 2003 |
Decrease in non-selective, non-sustained attention induced by a chronic visceral inflammatory state as a new pain evaluation in rats.
Topics: Acetaminophen; Analgesics; Animals; Anti-Inflammatory Agents; Aspirin; Attention; Behavior, Animal; | 2004 |
[Chronic diarrhea caused by NSAIDs].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Chronic Disease; Colitis; Collagen; Colonoscopy; D | 2004 |
[NSAID-colonopathy].
Topics: Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Colitis; Colon; Diagnosis, Differentia | 2006 |
[Epidemiology of gastrointestinal bleeding in the elderly].
Topics: Age Factors; Aged; Aged, 80 and over; Angiodysplasia; Anti-Inflammatory Agents, Non-Steroidal; Aspir | 2006 |
Proctocolitis induced by salicylate and associated with asthma and recurrent nasal polyps.
Topics: Aspirin; Asthma; Colitis; Double-Blind Method; Drug Hypersensitivity; Humans; Male; Middle Aged; Nas | 1983 |
Proctocolitis induced by salicylate.
Topics: Adult; Aspirin; Colitis; Humans; Male; Proctocolitis | 1984 |
[Damages to the large intestine induced by non-steroidal anti-inflammatory agents].
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Colitis; Colon; Female; Humans; Male; Napro | 1995 |
[Acute colitis secondary to taking aspirin].
Topics: Acute Disease; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Colitis; Female; Humans | 1999 |
Nonsteroidal anti-inflammatory drug-associated colitis with a histology of collagenous colitis.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Colitis; Collagen; Colonoscopy; Diarrhea; Fe | 2001 |
Effects of a COX-2 preferential agent nimesulide on TNBS-induced acute inflammation in the gut.
Topics: Acute Disease; Animals; Aspirin; Colitis; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygen | 2001 |
[Acute diarrhea caused by penicillin; bronchial asthma by aspirin; and dental hypoplasia induced by antiepileptic drugs].
Topics: Adult; Anticonvulsants; Aspirin; Asthma; Colitis; Dental Enamel Hypoplasia; Female; Humans; Odontoge | 1979 |
Naproxen-associated renal failure in a child with arthritis and inflammatory bowel disease.
Topics: Adolescent; Arthritis, Juvenile; Aspirin; Colitis; Drug Therapy, Combination; Female; Humans; Kidney | 1987 |
The bone marrow during recovery from drug induced agranulocytosis.
Topics: Agranulocytosis; Analgesics; Aspirin; Azepines; Bone Marrow; Bone Marrow Cells; Bone Marrow Examinat | 1972 |
Intermittent high dose oral methotrexate therapy in psoriasis.
Topics: Adult; Aged; Aspirin; Ataxia; Colitis; Female; Hematologic Diseases; Humans; Male; Methotrexate; Mid | 1970 |